Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Total Debt (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Total Debt for 2 consecutive years, with $52.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Debt rose 742.46% to $52.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $52.9 million, a 742.46% increase, with the full-year FY2025 number at $52.9 million, up 742.46% from a year prior.
  • Total Debt was $52.9 million for Q4 2025 at Nuvation Bio, roughly flat from $52.7 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $52.9 million in Q4 2025 to a low of $5.7 million in Q1 2025.